A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Imint Launches Powerful Video Stabilization Technology to Enhance Training and Remote Collaboration Within the Healthcare Industry

IMINT Image Intelligence AB(“Imint”), a global leader in video enhancement software, today launched Vidhance for Remote Assistance, a new suite of subscription-based tools designed to transform the quality of video content captured by remote assistance devices used in the healthcare industry for training and remote collaboration.
The new solution consists of the Vidhance Premium Video Stabilization feature, setting a new industry standard for unrivaled video stability, and the all-new Vidhance Click & Lock feature, empowering remote viewers to effortlessly select, track, and focus on on-screen objects regardless of camera movement.“
Remote assistance devices are indispensable for real-time collaboration among healthcare professionals–whether it’s traveling surgeon training students in Africa, or on-site nurse providing wound care while relying on remote support from an expert doctor in another country,” said Niclas Elvgren, Head of the Professional Solutions Business Unit at Imint.“Drawing upon our deep expertise in the smartphone video enhancement market, we’ve developed Vidhance for Remote Assistance to simplify the path for independent software vendors and solutions providers to enhance communication and control for healthcare scenarios, even where the movements of wearers are unstable.”
The Vidhance Premium Video Stabilization feature efficiently eliminates shakiness in real-time by keeping the frame stable and the horizon level for video captured on handheld, head-mounted, or body-worn cameras, while also correcting for lens distortions. The software achieves this feat by leveraging data from the camera’s motion sensors to calculate the optimal stabilization frame-by-frame –a robust and efficient method that has been battle-proven in over 850 million smartphones powered by Imint to date.
In addition to stabilizing and leveling the video stream, the Vidhance for Remote Assistance solution also provides remote viewers direct control over the video’s focus point through the all-new Vidhance Click & Lock feature. With a simple click, remote viewers can select an object on the live feed to lock onto it as the camera’s focus point, using automatic tracking and zooming to center the object regardless of how it or the camera wearer moves.
Vidhancefor Remote Assistance is offered through a subscription model that is completely free to developers. Solution providers that integrate the software suite can provide a free trial period for users, then offer a monthly or annual subscription for full-time adoption.
“We chose a convenient subscription model for these powerful video enhancement features because we want them to be available to all levels of developers to help foster further innovation,” Elvgren added. “Asthe remote assistance needs of healthcare professionals continue to evolve, we’re fully committed to developing new solutions that will enhance the communication between healthcare professionals through high-quality video, thus paving the way for mass market adoption.
”The Vidhance SDK has been developed to allow flexible implementation in the video pipeline from camera to viewer. Imint has a proven track record in the smartphone industry, partnering with many of the market’s most innovative companies to bring improved video performance to millions of smartphone users. Furthermore, Imint is also emerging as the video stabilization leader in the wearables market through collaboration with brands such as RealWear and Rokid.
For more information about Vidhancefor Remote Assistance, visit here.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy